Skip to main content
Equibles
ELMD logo

ELMD · Electromed, Inc. · Metrics

Track ELMD — free

Use ELMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ELMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$26.37 -0.50 (-1.86%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$220.62M
Shares
8.37M
Volume · Oct 23 40.38K Avg daily vol (3M) 86.16K

ELMD metrics

104 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$26.37
Market cap
$220.62M

Price action

20 metrics
Price change (1W)
-3.8%
Price change (30D)
-5.4%
Price change (3M)
-31.3%
Price change (6M)
-0.1%
Price change (YTD)
-9.4%
Price change (1Y)
+6.8%
Trailing year
Price change (5Y)
+141.7%
52-week high
$46.31
52-week low
$23.15
Change from 52-week high
-43.1%
Change from 52-week low
+13.9%
Annualized volatility
49.8%
Annualized volatility (3M)
47.7%
Beta
0.6
RSI (14D)
30.8
Price vs SMA 50
-11.3%
Price vs SMA 200
-15.8%
Avg volume (3M)
86,160
Relative volume
0.5
Average dollar volume
$2.71M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
8.37M

Valuation

12 metrics
P / E (TTM)
20.3
Trailing earnings · reciprocal yield 4.9%
PEG ratio
0.4
EV / revenue
2.7×
reciprocal yield 36.9%
EV / EBITDA
—
EV / EBIT
14.4×
reciprocal yield 6.9%
P / sales
3.0×
reciprocal yield 33.4%
P / book
4.1
reciprocal yield 24.5%
FCF yield
3.8%
TTM · current market cap
Buyback yield
1.8%
P / FCF
26.2
reciprocal yield 3.8%
P / operating cash flow
22.8
reciprocal yield 4.4%
Earnings yield
5.1%

Historical valuation

8 metrics
P / E historical average (3Y)
28.9×
reciprocal yield 3.5%
P / E historical average (5Y)
34.8×
reciprocal yield 2.9%
EV / revenue historical average (3Y)
3.1×
reciprocal yield 32.0%
EV / revenue historical average (5Y)
3.1×
reciprocal yield 32.0%
EV / EBIT historical average (3Y)
18.7×
reciprocal yield 5.4%
EV / EBIT historical average (5Y)
18.7×
reciprocal yield 5.4%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-25

Profitability

9 metrics
Gross margin
78.5%
Operating margin
18.8%
Trailing 12 months
Net margin
15.3%
Gross profit (TTM)
$57.94M
Operating profit (TTM)
$13.88M
Net income (TTM)
$11.30M
Trailing 12 months
Diluted EPS (TTM)
$1.30
FCF margin
11.4%
Effective tax rate
21.3%

Per share

11 metrics
Revenue per diluted share (TTM)
$8.49
Gross profit per diluted share (TTM)
$6.67
Operating profit per diluted share (TTM)
$1.60
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$1.30
Operating cash flow per diluted share (TTM)
$1.11
Free cash flow per diluted share (TTM)
$0.97
Capital expenditures per diluted share (TTM)
$0.14
R&D per diluted share (TTM)
$0.15
Stock compensation per diluted share (TTM)
$0.31
Book value per share
$6.45

Growth

11 metrics
Revenue growth YoY
+11.6%
Year over year
Net income growth YoY
+54.3%
Revenue (TTM)
$73.78M
Trailing 12 months
EPS growth YoY
+46.2%
Shares change YoY
-3.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+15.4%
Revenue CAGR (5Y)
+15.6%
EPS CAGR (3Y)
+53.4%
EPS CAGR (5Y)
+36.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+24.7%

Quality

14 metrics
Return on equity
20.9%
Return on assets
17.1%
Debt / equity
0.0
Current ratio
4.7
EBITDA (TTM)
—
Free cash flow (TTM)
$8.41M
Quick ratio
4.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
32.6%
Trailing 12 months
Net cash
$20.45M
Latest balance sheet
Cash & equivalents
$20.45M
Total assets
$66.27M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$9.66M
Capital expenditures (TTM)
$1.25M
R&D (TTM)
$1.31M
SG&A (TTM)
$42.75M
Stock compensation (TTM)
$2.72M
R&D / revenue
1.8%
Stock compensation / revenue
3.7%

Ownership (13F)

9 metrics
13F filers
129
13F filer change QoQ
+26
Institutional ownership
55.5%
Conviction holders (share of 13F filers)
0.8%
Crowding (high-turnover and private-fund holders)
17.8%
Private-fund adviser ownership
16.9%
Active holders' share change QoQ
+6.7%
Holder tenure
12.1
Price vs estimated holder cost
+77.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
9.8%

Short interest

3 metrics
Short interest
2.4%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1488917 CUSIP 285409108 13F (30d) 17 filings 17 filers Visit website Investor relations